DelveInsight has launched a new report on“Chronic Kidney Disease – Market Insights, Epidemiology, and Market Forecast-2030”.
DelveInsight’s “Chronic Kidney Disease – Market Insights, Epidemiology, and Market Forecast-2030″report delivers an in-depth understanding of the Chronic Kidney Disease, historical and forecasted epidemiology as well as the Chronic Kidney Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Report:
The total prevalent population of Chronic Kidney Disease (CKD) in the 7MM was 65,988,842 in 2017, during the study period [2017–2030]. Estimates show the highest prevalent population of Chronic Kidney Disease (CKD) is in the United States, with 37,809,570 cases in 2017.
The second most prevalent cases of Chronic Kidney Disease (CKD) in 7MM were recorded in Japan with 13,758,938 cases in 2017.
Key benefits of the report:
Chronic Kidney Disease market report covers a descriptive overview and comprehensive insight of the Chronic Kidney Disease epidemiology and Chronic Kidney Disease market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
The Chronic Kidney Disease market report provides insights on the current and emerging therapies.
Chronic Kidney Disease market report provides a global historical and forecasted market covering drug outreach in 7MM.
The Chronic Kidney Disease market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Chronic Kidney Disease market.
Got queries? Click here to know more about Chronic Kidney Disease Market Landscape.
Chronic Kidney Disease Overview
Chronic kidney disease (CKD) means your kidneys are damaged and can’t filter blood the way they should. The disease is called “chronic” because the damage to your kidneys happens slowly over a long period of time. This damage can cause wastes to build up in your body.
The key players involved in the Chronic Kidney Disease market:
FibroGen/ Astellas Pharma/ AstraZeneca
The launch of the emerging therapies is expected to significantly impact the Chronic Kidney Disease treatment scenario in the upcoming years:-
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Chronic Kidney Disease Patient Share (%) Overview at a Glance
5. Chronic Kidney Disease Market Overview at a Glance
6. Chronic Kidney Disease Disease Background and Overview
7. Chronic Kidney Disease Epidemiology and Patient Population
8. Country-Specific Patient Population of Chronic Kidney Disease
9. Chronic Kidney Disease Current Treatment and Medical Practices
10. Unmet Needs
11. Chronic Kidney Disease Emerging Therapies
12. Chronic Kidney Disease Market Outlook
13. Country-Wise Chronic Kidney Disease Market Analysis (2017–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
18. Chronic Kidney Disease Report Methodology
19. DelveInsight Capabilities
21. About DelveInsight
“Chronic Kidney Disease Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Chronic Kidney Disease market. A detailed picture of the Chronic Kidney Disease pipeline landscape is provided, which includes the disease overview and Chronic Kidney Disease treatment guidelines.
DelveInsight’s ‘Chronic Kidney Disease Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Chronic Kidney Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States